Alimentary Pharmacology & Therapeutics

© 2013 Blackwell Publishing Ltd

Cover image for Vol. 35 Issue 7

April 2012

Volume 35, Issue 7

Pages 745–864

  1. SYSTEMATIC REVIEW

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have full text access to this OnlineOpen article
      Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders (pages 745–767)

      J. Tack, M. Camilleri, L. Chang, W. D. Chey, J. J. Galligan, B. E. Lacy, S. Müller-Lissner, E. M. M. Quigley, J. Schuurkes, J. H. De Maeyer and V. Stanghellini

      Article first published online: 22 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05011.x

  2. REVIEW ARTICLE

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have free access to this content
      Review article: coeliac disease, new approaches to therapy (pages 768–781)

      S. Rashtak and J. A. Murray

      Article first published online: 13 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05013.x

  3. RANDOMISED CLINICAL TRIAL

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea (pages 782–788)

      A. Passariello, G. Terrin, G. Cecere, M. Micillo, G. De Marco, M. Di Costanzo, L. Cosenza, L. Leone, R. Nocerino and R. Berni Canani

      Article first published online: 13 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05015.x

  4. NFLAMMATORY BOWEL DISEASE

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease (pages 789–795)

      A. N. Ananthakrishnan, R. Guzman-Perez, V. Gainer, T. Cai, S. Churchill, I. Kohane, R. M. Plenge and S. Murphy

      Article first published online: 23 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05022.x

  5. PEPTIC ULCER BLEEDING

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study (pages 796–802)

      K.-W. Huang, J.-C. Luo, H.-B. Leu, H.-C. Lin, F.-Y. Lee, W.-L. Chan, S.-J. Lin, J.-W. Chen and F.-Y. Chang

      Article first published online: 21 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05028.x

  6. BARRETT'S OESOPHAGUS

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy (pages 803–809)

      L. B. Gerson, S. Mitra, W. F. Bleker and P. Yeung

      Article first published online: 22 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05016.x

  7. ACID INHIBITION

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism (pages 810–818)

      N. G. Hunfeld, D. J. Touw, R. A. Mathot, R. H. van Schaik and E. J. Kuipers

      Article first published online: 13 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05014.x

  8. NSAID MUCOSAL INJURY

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules (pages 819–827)

      C. Hawkey, I. Burnett, M. S. Gold, K. Garsed, D. Stevenson, J. Mannath, A. Norman, V. Shepherd, V. Subramanian, R. D. Johnston and M. Brown

      Article first published online: 28 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05030.x

  9. IRRITABLE BOWEL SYNDROME

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have free access to this content
      Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome (pages 828–838)

      C. Chassard, M. Dapoigny, K. P. Scott, L. Crouzet, C. Del'homme, P. Marquet, J. C. Martin, G. Pickering, D. Ardid, A. Eschalier, C. Dubray, H. J. Flint and A. Bernalier-Donadille

      Article first published online: 8 FEB 2012 | DOI: 10.1111/j.1365-2036.2012.05007.x

  10. INVITED COMMENTARIES

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have free access to this content
      Commentary: coeliac disease, mortality and malignancy (pages 839–840)

      J. F. Ludvigsson

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05005.x

    2. You have free access to this content
      Commentary: coeliac disease, mortality and malignancy – authors’ reply (pages 840–842)

      M. Tio, M. R. Cox and G. D. Eslick

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05017.x

    3. You have free access to this content
      Commentary: HBsAg levels as predictor of sustained response to peg interferon in HBeAg-negative chronic hepatitis B (pages 842–843)

      S. J. Hadziyannis

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05009.x

    4. You have free access to this content
      Commentary: HBsAg levels as predictor of sustained response to peginterferon in HBeAg-negative chronic hepatitis B – author's reply (pages 843–844)

      C.-Y. Peng

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05020.x

    5. You have free access to this content
      Commentary: effect of pregabalin on acid-induced oesophageal hypersensitivity (pages 844–845)

      T. H. Oh and R. Fass

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05018.x

    6. You have free access to this content
      Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis (page 846)

      C. Santander and R. Moreno-Otero

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05019.x

    7. You have free access to this content
      Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis – authors’ reply (page 847)

      L. Lindström and A. Bergquist

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05032.x

    8. You have free access to this content
      Commentary: BMI and the need for adalimumab dose escalation in Crohn's disease (page 848)

      G. Van Assche, F. Baert and S. Vermeire

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05023.x

    9. You have free access to this content
      Commentary: BMI and the need for adalimumab dose escalation in Crohn's disease – authors’ reply (page 849)

      E. Bultman and C. J. van der Woude

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05045.x

    10. You have free access to this content
      Commentary: short-term stability of subtypes in the irritable bowel syndrome (pages 849–850)

      R. K. Wong and D. A. Drossman

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05004.x

    11. You have free access to this content
      Commentary: short-term stability of subtypes in the irritable bowel syndromes – authors’ reply (pages 850–851)

      A. L. Engsbro*, M. Simrén and P. Bytzer

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05008.x

  11. LETTERS TO THE EDITORS

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have free access to this content
      Letter: the ethics of using inferior regimens in H. pylori randomised trials (pages 852–854)

      D. Y. Graham and L. A. Fischbach

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2011.04944.x

    2. You have free access to this content
      Letter: the ethics of using inferior regimens in H. pylori randomised trials – invited comment (pages 854–856)

      J. P. Anthony O'Connor and C. A. O'Morain

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2011.04951.x

    3. You have free access to this content
      Letter: the ethics of using inferior regimens in H. pylori randomised trials – invited comment (pages 856–857)

      J. P. Gisbert

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2011.04985.x

    4. You have free access to this content
      Letter: the ethics of using inferior regimens in H. pylori randomised trials – editors’ reply (page 858)

      R. E. Pounder and N. J. Talley

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05024.x

    5. You have free access to this content
      Letter: identication of probiotics by specific strain name (pages 859–860)

      R. Francavilla, C. Fontana and F. Cristofori

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05010.x

    6. You have free access to this content
      Letter: identification of probiotics by specific strain name – author’s reply (page 860)

      Y. Vandenplas

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05026.x

    7. You have free access to this content
      Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation (pages 861–862)

      M. Saito, Y. Seo, Y. Yano, A. Miki, K. Momose, H. Hirano, M. Yoshida and T. Azuma

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05021.x

    8. You have free access to this content
      Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation – authors’ reply (pages 862–863)

      G. Cabibbo, C. Genco and C. Cammà

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05042.x

  12. CORRIGENDA

    1. Top of page
    2. SYSTEMATIC REVIEW
    3. REVIEW ARTICLE
    4. RANDOMISED CLINICAL TRIAL
    5. NFLAMMATORY BOWEL DISEASE
    6. PEPTIC ULCER BLEEDING
    7. BARRETT'S OESOPHAGUS
    8. ACID INHIBITION
    9. NSAID MUCOSAL INJURY
    10. IRRITABLE BOWEL SYNDROME
    11. INVITED COMMENTARIES
    12. LETTERS TO THE EDITORS
    13. CORRIGENDA
    1. You have free access to this content
      Corrigenda (page 864)

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05012.x

      This article corrects:

      Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease – a population-based study

      Vol. 34, Issue 10, 1217–1224, Article first published online: 9 OCT 2011

    2. You have free access to this content
      Corrigenda (page 864)

      Article first published online: 8 MAR 2012 | DOI: 10.1111/j.1365-2036.2012.05036.x

      This article corrects:

      Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C

      Vol. 34, Issue 11-12, 1306–1317, Article first published online: 17 OCT 2011

SEARCH

SEARCH BY CITATION